Senior insider sale
CRISPR THERAPEUTICS AG — senior position signals high conviction
$780.9K
13.68K shares
What this filing means
BEHBAHANI ALI plans to sell 13.68K shares of CRISPR THERAPEUTICS AG valued at approximately $780.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001950047-26-009604
13.68K
Shares to sell
$780.9K
Approx. market value
13.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/17/2026
13.68KTotal acquired13.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Stock Option Exercise Cash | 13.68K | — |
| Total | 13.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.68K
Market value
$780.9K
9/17/2026
Total
Units
13.68K
Value
$780.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/17/2026 | 13.68K | $780.9K | NASDAQ | Planned |
| Total | 13.68K | $780.9K | ||